Research

Hormonal

Anti-obesity medications (AOMs), particularly semaglutide, produce statistically significant weight reduction in older adults (≥65 years), with the strongest evidence supporting their use in those with established cardiovascular disease.

If you are 65 or older and have obesity, anti-obesity medications like semaglutide can help you lose weight, especially if you have heart disease. The weight loss is significant (around 7-8% in major trials), but you may experience more side effects like nausea or dizziness. Work with your doctor to start slowly and monitor your health.

ModerateSupportsMEDIUM confidence
All studies found statistically significant weight reduction between intervention and placebo group or compared to baseline weight... Limited evidence suggests weight reduction of AOMs in older adults, with the best current evidence for the use of semaglutide in older adults with obesity and cardiovascular disease.
Alissa S. Chen et al. · Obesity · 2024

Why this rating

Based on a systematic review of 8 studies (6 experimental, 2 observational), but limited by small sample sizes of older adults, high risk of bias in some trials, and lack of long-term data.

Source

Efficacy of antiobesity medications for weight reduction in older adults: a systematic review

Alissa S. Chen et al. · Obesity · 2024

DOI 10.1002/oby.24160

systematic_reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →